ANALYSIS AT THE MOLECULAR LEVEL OF THE INTERACTION BETWEEN ALPHA-DYSTROGLYCAN AND BETA-DYSTROGLYCAN AND ASSESSMENT OF ITS IMPLICATION FOR SKELETAL MUSCLE PHYSIOPATHOLOGY
- 3 Years 2006/2009
- 120.000€ Total Award
All multicellular living organisms are surrounded by the extracellular matrix, a well-organized network formed by collagens, laminins and proteoglycans. Dystroglycan (DG) is localized at the cell surface and it is formed by two interacting subunits. DG represents one of the major adhesion complex that links the intracellular cytoskeleton to the extracellular matrix. In particular, in skeletal muscle DG interacts with a specialized form of extracellular matrix (basement membrane) ensuring stability to muscle fibers during the cycles of contraction and relaxation. Several muscular pathologies are characterized by an altered molecular structure of DG. Nonetheless, the details of DG involvement in neuromuscular diseases have yet to be fully clarified. The aim of our project is to shed new light on the molecular aspects of dystroglycan subunits crosstalk to better understand the role of DG in neuromuscular pathologies
Scientific Publications
- 2009 IUBMB LIFE
Enzymatic Processing of beta-Dystroglycan Recombinant Ectodomain By MMP-9: Identification of the Main Cleavage Site
- 2012 BMC BIOCHEMISTRY
Insertion of a myc-tag within alpha-dystroglycan domains improves its biochemical and microscopic detection
- 2012 EXPERIMENTAL CELL RESEARCH
Dystroglycan is associated to the disulfide isomerase ERp57
- 2009 MATRIX BIOLOGY
Functional diversity of dystroglycan
- 2011 THE OPEN NEUROLOGY JOURNAL
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients
- 2007 TRENDS IN BIOTECHNOLOGY
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
- 2006 JOURNAL OF BIOLOGICAL CHEMISTRY
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin
- 2009 FEBS Journal
Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor